1. S. Görög , Identification and Determination of Impurities in Drugs, Elsevier Inc., 2000
2. ICH , Q1A(R2) – Stability Testing of New Drug Substances and Products, Geneva, 2003
3. J. Swarbrick , N.Carolina, L. L.Augsburger, H. G.Brittain, A. J.Hickey and C.Hill, Pharmaceutical Stress Testing, Taylor & Francis Group, LLC, 2005
4. The role of degradant profiling in active pharmaceutical ingredients and drug products☆
5. Salt formation to improve drug solubility